XML 18 R6.htm IDEA: XBRL DOCUMENT v3.22.2
Condensed Statements of Stockholders' Equity - USD ($)
$ in Thousands
Common Stock
Additional Paid-In Capital
Accumulated Deficit
Total
Balance at Dec. 31, 2020 $ 2 $ 174,584 $ (157,174) $ 17,412
Balance (in shares) at Dec. 31, 2020 19,031,556      
Increase (Decrease) in Stockholders' Equity        
Exercise of stock options   144   144
Exercise of stock options (in shares) 54,077      
Issuance of common stock under stock incentive plans   364   364
Issuance of common stock under stock incentive plans (in shares) 136,709      
Stock-based compensation expense   743   743
Net income (loss)     (460) (460)
Balance at Mar. 31, 2021 $ 2 175,835 (157,634) 18,203
Balance (in shares) at Mar. 31, 2021 19,222,342      
Balance at Dec. 31, 2020 $ 2 174,584 (157,174) 17,412
Balance (in shares) at Dec. 31, 2020 19,031,556      
Increase (Decrease) in Stockholders' Equity        
Net income (loss)       (204)
Balance at Jun. 30, 2021 $ 2 176,688 (157,378) 19,312
Balance (in shares) at Jun. 30, 2021 19,435,274      
Balance at Mar. 31, 2021 $ 2 175,835 (157,634) 18,203
Balance (in shares) at Mar. 31, 2021 19,222,342      
Increase (Decrease) in Stockholders' Equity        
Exercise of stock options   57   57
Exercise of stock options (in shares) 23,280      
Issuance of common stock under stock incentive plans   92   92
Issuance of common stock under stock incentive plans (in shares) 189,652      
Stock-based compensation expense   704   704
Net income (loss)     256 256
Balance at Jun. 30, 2021 $ 2 176,688 (157,378) 19,312
Balance (in shares) at Jun. 30, 2021 19,435,274      
Balance at Dec. 31, 2021 $ 2 180,067 (152,831) 27,238
Balance (in shares) at Dec. 31, 2021 19,858,460      
Increase (Decrease) in Stockholders' Equity        
Exercise of stock options   69   69
Exercise of stock options (in shares) 15,830      
Issuance of common stock under stock incentive plans (in shares) 96,496      
Stock-based compensation expense   824   824
Net income (loss)     1,935 1,935
Balance at Mar. 31, 2022 $ 2 180,960 (150,896) 30,066
Balance (in shares) at Mar. 31, 2022 19,970,786      
Balance at Dec. 31, 2021 $ 2 180,067 (152,831) $ 27,238
Balance (in shares) at Dec. 31, 2021 19,858,460      
Increase (Decrease) in Stockholders' Equity        
Exercise of stock options (in shares)       33,961
Net income (loss)       $ 3,606
Balance at Jun. 30, 2022 $ 2 182,488 (149,225) 33,265
Balance (in shares) at Jun. 30, 2022 20,137,520      
Balance at Mar. 31, 2022 $ 2 180,960 (150,896) 30,066
Balance (in shares) at Mar. 31, 2022 19,970,786      
Increase (Decrease) in Stockholders' Equity        
Exercise of stock options   50   50
Exercise of stock options (in shares) 18,131      
Issuance of common stock under stock incentive plans   167   167
Issuance of common stock under stock incentive plans (in shares) 148,603      
Stock-based compensation expense   1,311   1,311
Net income (loss)     1,671 1,671
Balance at Jun. 30, 2022 $ 2 $ 182,488 $ (149,225) $ 33,265
Balance (in shares) at Jun. 30, 2022 20,137,520